| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240402 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
IAI of 188Re-Lip in developing countries is feasible, safe, cost-effective, and deserves a phase III trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Patricia M.D., Jean-Luc M.D., Ph.D., Gaj Ph.D., Erdenechimeg M.D., Felix X. M.D., Ajay M.D., Jae Min M.D., Ph.D., Pawana M.D., Chaitanya M.D., Ph.D., Pat M.D., Ph.D., Janez M.D., Ph.D., John M.D., Chau Trinh Thi M.D., Maung Maung Ph.D., Shaoliang M.D.,